Cargando…

Screening of disease-related biomarkers related to neuropathic pain (NP) after spinal cord injury (SCI)

BACKGROUND: Based on the molecular expression level, this paper compares lncRNA and mRNA expressions respectively in peripheral blood samples of the patients after SCI with NP and without NP, and screens disease-related biomarkers related to NP after SCI in peripheral blood samples of patients. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jia, Yang, Li, Huang, Limin, Li, Zinan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831171/
https://www.ncbi.nlm.nih.gov/pubmed/33494823
http://dx.doi.org/10.1186/s40246-021-00303-w
_version_ 1783641580325830656
author Zhao, Jia
Yang, Li
Huang, Limin
Li, Zinan
author_facet Zhao, Jia
Yang, Li
Huang, Limin
Li, Zinan
author_sort Zhao, Jia
collection PubMed
description BACKGROUND: Based on the molecular expression level, this paper compares lncRNA and mRNA expressions respectively in peripheral blood samples of the patients after SCI with NP and without NP, and screens disease-related biomarkers related to NP after SCI in peripheral blood samples of patients. METHOD: The expression spectrum of 25 human peripheral blood samples (12 samples of refractory NP patients after SCI) was downloaded and data were normalized. Screening of GO annotations significantly associated with significant differentially expressed mRNAs and significant involvement of the KEGG pathway. The WGCNA algorithm was used to screen for modules and RNAs that were significantly associated with disease characterization. A co-expression network was constructed to extract the genes involved in the disease pathway from the co-expression network, construct a network of SCI pain-related pathways, and screen important disease-related biomarkers. Quantitative real-time PCR was used to detect the mRNA expression of hub genes. RESULTS: Data were normalized and re-annotated by detection of platform information, resulting in a total of 289 lncRNA and 18197 mRNAs. Screening resulted in 338 significant differentially expressed RNAs that met the threshold requirements. Differentially expressed RNAs were significantly enriched with the brown and magenta modules. Six KEGG signaling pathways were screened in the co-expression network, and three KEGG pathways with direct neuropathic pain were identified. The expression levels of E2F1, MAX, MITF, CTNNA1, and ADORA2B in the disease group were all significantly upregulated (p < 0.01). Compared with the normal group, the expression of OXTR was upregulated. CONCLUSION: We speculate that there are 7 genes and 2 lncRNAs directly involved in the pain pathway: E2F1, MAX, MITF, CTNNA1, ADORA2B, GRIK3, OXTR, LINC01119, and LINC02447. These molecules may be important for NP after SCI. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40246-021-00303-w.
format Online
Article
Text
id pubmed-7831171
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78311712021-01-26 Screening of disease-related biomarkers related to neuropathic pain (NP) after spinal cord injury (SCI) Zhao, Jia Yang, Li Huang, Limin Li, Zinan Hum Genomics Primary Research BACKGROUND: Based on the molecular expression level, this paper compares lncRNA and mRNA expressions respectively in peripheral blood samples of the patients after SCI with NP and without NP, and screens disease-related biomarkers related to NP after SCI in peripheral blood samples of patients. METHOD: The expression spectrum of 25 human peripheral blood samples (12 samples of refractory NP patients after SCI) was downloaded and data were normalized. Screening of GO annotations significantly associated with significant differentially expressed mRNAs and significant involvement of the KEGG pathway. The WGCNA algorithm was used to screen for modules and RNAs that were significantly associated with disease characterization. A co-expression network was constructed to extract the genes involved in the disease pathway from the co-expression network, construct a network of SCI pain-related pathways, and screen important disease-related biomarkers. Quantitative real-time PCR was used to detect the mRNA expression of hub genes. RESULTS: Data were normalized and re-annotated by detection of platform information, resulting in a total of 289 lncRNA and 18197 mRNAs. Screening resulted in 338 significant differentially expressed RNAs that met the threshold requirements. Differentially expressed RNAs were significantly enriched with the brown and magenta modules. Six KEGG signaling pathways were screened in the co-expression network, and three KEGG pathways with direct neuropathic pain were identified. The expression levels of E2F1, MAX, MITF, CTNNA1, and ADORA2B in the disease group were all significantly upregulated (p < 0.01). Compared with the normal group, the expression of OXTR was upregulated. CONCLUSION: We speculate that there are 7 genes and 2 lncRNAs directly involved in the pain pathway: E2F1, MAX, MITF, CTNNA1, ADORA2B, GRIK3, OXTR, LINC01119, and LINC02447. These molecules may be important for NP after SCI. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40246-021-00303-w. BioMed Central 2021-01-25 /pmc/articles/PMC7831171/ /pubmed/33494823 http://dx.doi.org/10.1186/s40246-021-00303-w Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Primary Research
Zhao, Jia
Yang, Li
Huang, Limin
Li, Zinan
Screening of disease-related biomarkers related to neuropathic pain (NP) after spinal cord injury (SCI)
title Screening of disease-related biomarkers related to neuropathic pain (NP) after spinal cord injury (SCI)
title_full Screening of disease-related biomarkers related to neuropathic pain (NP) after spinal cord injury (SCI)
title_fullStr Screening of disease-related biomarkers related to neuropathic pain (NP) after spinal cord injury (SCI)
title_full_unstemmed Screening of disease-related biomarkers related to neuropathic pain (NP) after spinal cord injury (SCI)
title_short Screening of disease-related biomarkers related to neuropathic pain (NP) after spinal cord injury (SCI)
title_sort screening of disease-related biomarkers related to neuropathic pain (np) after spinal cord injury (sci)
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831171/
https://www.ncbi.nlm.nih.gov/pubmed/33494823
http://dx.doi.org/10.1186/s40246-021-00303-w
work_keys_str_mv AT zhaojia screeningofdiseaserelatedbiomarkersrelatedtoneuropathicpainnpafterspinalcordinjurysci
AT yangli screeningofdiseaserelatedbiomarkersrelatedtoneuropathicpainnpafterspinalcordinjurysci
AT huanglimin screeningofdiseaserelatedbiomarkersrelatedtoneuropathicpainnpafterspinalcordinjurysci
AT lizinan screeningofdiseaserelatedbiomarkersrelatedtoneuropathicpainnpafterspinalcordinjurysci